×

Access all guidelines and regulatory updates on

QuriousRI
×

Access all guidelines and regulatory updates on

QuriousRI

Artixio

Pharmaceutical Regulatory Support In South Korea

MFDS Pharmaceutical Compliance Support in South Korea

Get expert pharmaceutical compliance consulting in South Korea. Artixio supports MFDS submissions, audits, regulatory strategy, and product lifecycle compliance.

Artixio is a global regulatory service provider company, helping our clients to successfully launch their product in the market and maintaining post-approval surveillance. In the South Korea, we offer a complete support for industries throughout their journey of pharmaceutical commercialization with the Ministry of Food and Drug Safety (MFDS).

Regulatory consulting expertise

Regulatory Affairs

Product Registration Compliance strategy consult

Product Registration

IND Regulatory portfolio management

IND (Investigational New Drug)

Regulatory portfolio management for New drugs

NDA (New Drug Application)

Compliance and regulatory consulting – Artixio
Technical Writing expertise

Technical Writing

regulatory strategy expertise

Regulatory Strategy

Regulatory compliance consulting

Digital Marketing

Market access Regulatory consulting support

Market Access

Regulatory operations regulatory services

Regulatory Operations

Pharma Compliance Consulting & MFDS Support in South Korea

The Ministry of Food and Drug Safety (MFDS) is the National Regulatory Authority regulating the registration of pharmaceuticals with South Korea.
In the South Korea, Pharmaceuticals are classified into the following two categories:
Drug Products further includes:
Before registering the product with South Korea, it is crucial to identify the proper classification category of a product. At Artixio, we help our clients to determine the appropriate Product Category and regulatory requirements in compliance with the South Korea MFDS.

MFDS Approval Process for Pharmaceuticals in South Korea

Following steps are involved to successfully register a pharmaceutical product with South Korea (MFDS):

Before issuing the Approval, MFDS carries out the inspection of manufacturing sites and management practices

Artixio provides:

FAQs

What is the validity period of drug product approval with MFDS?
The validity period of a drug product is five years from the date of product approval.
As per South Korea MFDS, Post-Approval Changes are submitted in the following categories:
  • Annual report
  • Immediate report
  • Prior Change Approval 

The validity of Certificate of GMP Compliance is as follows:

Condition

Validity of GMP Compliance Certificate

First issuance

3 years from the issue date

Renewal after inspection

3 years from the completion date of GMP inspection

Changes made before expiry (e.g., addition of new dosage forms)

Existing certificate Expiration date stays the same 

Yes, the Global Innovative products on Fast Track (GIFT) Program under the MFDS promote expedited regulatory review of global innovative products to facilitate the market launch of innovative medicinal products for treatment of life-threatening or serious diseases, such as cancers, or rare diseases. Through the GIFT, the assessment timeline is shortened to up to 75% of usual review time (120 to 90 working days).
As per the MFDS, South Korea the applicable fees for approval of pharmaceutical manufacturing through online is 385,700 KRW and through in person/mailing is 426,300 KRW.
KRW: South Korean Won

Why Choose Artixio?

Regulatory approval consulting

Strategies for pre-submission preparation

Regulatory submission services

Support across INDs, NDAs, variations, and renewals

Regulatory approval consulting

Experience in licensing and maintaining 5000+ Products

Regulatory documentation support

Client focused support in applicable languages

Regulatory project consulting

Help with Korean-language requirements and labeling

Industries We Serve in the South Korea

Regulatory and compliance expert – Artixio

Pharmaceuticals

Medical device regulatory services – Artixio

MedTech

Cosmetics regulatory consulting – Artixio

Cosmetics

Nutrition regulatory consulting – Artixio

Nutrition

Biologics regulatory consulting – Artixio

Biologics

Veterinary regulatory consulting – Artixio

Veterinary

Regulatory Expertise Across
Multiple Countries

India Artixio – Regulatory affairs consulting expert
India
Vietnam Artixio – Regulatory affairs consulting expert
Vietnam
Mexico Artixio – Regulatory affairs consulting expert
Mexico​
Vietnam Artixio – Regulatory affairs consulting expert
Vietnam
US FDA Professional life sciences consulting – Artixio
United States
Brazil Artixio – Regulatory affairs consulting expert
Brazil
Europe Artixio – Regulatory affairs consulting expert
Europe
Malaysia Artixio – Regulatory affairs consulting expert
Malaysia
Taiwan Artixio – Regulatory affairs consulting expert
Taiwan
China Artixio – Regulatory affairs consulting expert
China
Thailand Artixio – Regulatory affairs consulting expert
Thailand
Philippines Artixio – Regulatory affairs consulting expert
Philippines

Insights from Artixio - Tips & Articles

Orphan Drug Designation in South Korea (MFDS)

Orphan Drug Designation in

Orphan Drug Designation (ODD) is regulated by Ministry of Food and Drug Safety (MFDS)...

February 10, 2026
Biologics and Biosimilars Regulations and Registration in South Korea

Biologics and Biosimilars Regulations

The Korean pharmaceutical market is estimated to be worth $24.3 billion in 2019, and...

February 10, 2026
Nutraceutical Regulation and Registration in South Korea (MFDS)

Nutraceutical Regulation and Registration

Today, we eat to ease hunger and don’t have the time to consider what...

February 10, 2026

Get in touch

×